---
title: "Huawei's enterprise-level intelligent agent development platform AgentArts will enter public beta on April 30"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/279765109.md"
description: "On March 19, at the 2026 Huawei China Partner Conference, Huawei Executive Director Wang Tao revealed that Huawei's enterprise-level intelligent agent development platform AgentArts will be publicly tested on April 30, and its open-source enhanced version will be released on May 30"
datetime: "2026-03-19T10:12:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/279765109.md)
  - [en](https://longbridge.com/en/news/279765109.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/279765109.md)
generator: "portal-rs"
---

# Huawei's enterprise-level intelligent agent development platform AgentArts will enter public beta on April 30

On March 19, at the 2026 Huawei China Partner Conference, Huawei Executive Director Wang Tao revealed that Huawei's enterprise-level intelligent agent development platform AgentArts will enter public testing on April 30, and its open-source enhanced version will be released on May 30

### Related Stocks

- [301218.CN](https://longbridge.com/en/quote/301218.CN.md)

## Related News & Research

- [Overvalued? This tech-to-savings ratio flirting with 'extreme' territory](https://longbridge.com/en/news/296136652.md)
- [Billionaire Izzy Englander bought SpaceX before the lockup expiration. Does he know something most investors don't?](https://longbridge.com/en/news/296209860.md)
- [Saudi Arabia's PIF releases annual report](https://longbridge.com/en/news/296178541.md)
- [Exclusive: Marjorie Taylor Greene Warns Social Security Will Go ‘Bankrupt’—But Wall Street CIO Backs Scott Bessent Amid 30-Year Yield Surge](https://longbridge.com/en/news/296329487.md)
- [Canada minister in charge of US trade ties heading to Washington, will meet with Greer](https://longbridge.com/en/news/296496134.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**